Login to Your Account



India Court Upholds Higher Patent Standard for Drugs

By Mari Serebrov
Washington Editor

Tuesday, April 2, 2013
Recognizing the global impact its decision could have, the Supreme Court of India denied an appeal by Novartis AG, ending the company's 15-year quest for a patent for its cancer drug Gleevec/Glivec.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription